Puma Biotechnology

Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. Its focus on in-licensing innovative drug candidates that are undergoing or have already completed initial clinical testing for the treatment of various forms of cancer and then seek to further develop these drug candidates for commercial use.

Type
Public
HQ
Los Angeles, US
Founded
2010
Size (employees)
160 (est)+3%
Puma Biotechnology was founded in 2010 and is headquartered in Los Angeles, US

Key People at Puma Biotechnology

Alan H. Auerbach

Alan H. Auerbach

Chief Executive Officer, President
Troy Wilson

Troy Wilson

Member of the Board of Directors

Puma Biotechnology Office Locations

Puma Biotechnology has offices in Los Angeles and San Francisco
Los Angeles, US (HQ)
10880 Wilshire Blvd

Puma Biotechnology Data and Metrics

Puma Biotechnology Financial Metrics

USD

Net income (FY, 2013)

(139.3 m)

EBIT (FY, 2013)

(139.4 m)

Market capitalization (23-Jun-2017)

3.2 b

Closing share price (23-Jun-2017)

86.5

Cash (31-Dec-2016)

194.5 m
Puma Biotechnology's current market capitalization is $3.2 b.
USDFY, 2013

Operating expense total

139.4 m

EBIT

(139.4 m)

Net Income

(139.3 m)
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

43 m38.5 m31.6 m194.5 m

Current Assets

96.4 m149.4 m223.5 m236.5 m

PP&E

1.7 m2.2 m2.4 m5.2 m

Total Assets

104.4 m162.8 m239.8 m252.8 m

Accounts Payable

10.7 m15 m17.8 m20 m

Current Liabilities

19.3 m44.4 m32.4 m37.5 m

Additional Paid-in Capital

223.2 m399.2 m726.7 m1 b

Retained Earnings

(281.2 m)(520.5 m)(796.5 m)

Total Equity

84 m117 m206 m209.8 m

Financial Leverage

1.2 x1.4 x1.2 x1.2 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(54.7 m)(142 m)(239.3 m)(276 m)

Depreciation and Amortization

423 k627 k776 k1.1 m

Accounts Payable

10.2 m4.3 m2.8 m2.2 m

Cash From Operating Activities

(55 m)(77.2 m)(154.5 m)(141.7 m)

Purchases of PP&E

(624 k)(1.1 m)(1 m)(4.3 m)

Cash From Investing Activities

(41.5 m)(63.3 m)(85.9 m)142.2 m

Cash From Financing Activities

2.2 m136 m233.4 m162.4 m
Y, 2016

Financial Leverage

1.2 x

Puma Biotechnology Market Value History

Puma Biotechnology News and Updates

Puma Biotechnology Company Life and Culture

You may also be interested in